New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2013
07:23 EDTARIAConcerns about ARIAD overblown, says RBC Capital
RBC Capital believes that key investor concerns about thrombotic arterial events and hypertension linked to ARIAD's Iclusig are overblown. The firm doesn't expect adverse events raised by a study of the drug to significantly affect the drug's launch or an upcoming Phase III study. RBC Capital maintains an Outperform rating on the stock.
News For ARIA From The Last 14 Days
Check below for free stories on ARIA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2014
10:07 EDTARIAARIAD has a conference call hosted by JPMorgan
JPMorgan Analysts Meacham and Kasimov will host a conference call with CEO Harvey Berger on April 10 at 10 am.
April 2, 2014
07:35 EDTARIAARIAD appoints Hugh Cole as Chief Business Officer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use